Sai Sreyas Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 8.00 Cr
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.75 Cr
- Revenue Growth 7350.52%
- Profit Growth -189.83%
- Ebitda 1658.44%
- Net Worth 113.12%
- Total Assets 50.52%
About Sai Sreyas Pharmaceutical
Sai Sreyas Pharmaceutical Private Limited (SSPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 May 2010 and has a history of 14 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.00 Cr.
The company currently has active open charges totaling ₹29.75 Cr.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232TG2010PTC068382
-
Company No.
068382
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sai Sreyas Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devereddy Reddy
|
Director | 15-Dec-2011 | Current |
|
Bakireddy Reddy
|
Director | 17-Feb-2020 | Current |
|
Saraswathi Bakireddy
|
Director | 19-Jun-2019 | Current |
|
Dileep Bakireddy
|
Director | 21-Jan-2021 | Current |
Financial Performance of Sai Sreyas Pharmaceutical.
Sai Sreyas Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 7350.52% increase. The company also saw a substantial fall in profitability, with a 189.83% decrease in profit. The company's net worth Soared by an impressive increase of 113.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Sreyas Pharmaceutical?
In 2023, Sai Sreyas Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Primoris Systems India Private LimitedBakireddy Reddy and Saraswathi Bakireddy are mutual person
-
Corey Organics Private LimitedDevereddy Reddy and Dileep Bakireddy are mutual person
-
Advantage One Human Resourcing Private LimitedBakireddy Reddy and Saraswathi Bakireddy are mutual person
-
Sri Chavadi Pharma Private LimitedDevereddy Reddy and Dileep Bakireddy are mutual person
-
Sjd Developers Private Limited
Devereddy Reddy, Bakireddy Reddy and 2 more are mutual person
-
Hexaforce Solutions Llp
Bakireddy Reddy and Saraswathi Bakireddy are mutual person
Charges (Loans)
₹29.75 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 29.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2021 | State Bank Of India | ₹29.75 Cr | Open |
How Many Employees Work at Sai Sreyas Pharmaceutical?
Sai Sreyas Pharmaceutical has a workforce of 66 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Sreyas Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Sreyas Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
